Viral Hepatitis Screening and Diagnosis (HAV and HBV)
Also known as: Hepatitis, Hepatitis A, Hepatitis B
Use
Aid in the diagnosis of viral hepatitis due to infection with HAV and/or HBV.
Special Instructions
Not provided.
Limitations
The assays in this panel have not been FDA cleared or approved for the screening of blood or plasma donors. Performance characteristics have not been established for immunocompromised or immunosuppressed patients, cord blood, or patients less than 2 years of age. The assay performance characteristics have not been determined for use in cadaveric specimens.
Methodology
Immunoassay (CLIA)
Biomarkers
LOINC Codes
- 95205-1 - HBV surface Ab Pnl SerPl
- 5196-1 - HBV surface Ag SerPl Ql IA
- 22322-2 - HBV surface Ab Ser Ql
- 13952-7 - HBV core Ab SerPl Ql IA
- 56850-1 - Imp & review of lab results
- 13951-9 - HAV Ab Ser Ql IA
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
7 mL
Minimum Volume
3 mL
Container
Gel-barrier tube, red-top tube or serum transfer tube
Collection Instructions
If tube other than a gel-barrier tube is used, transfer separated serum to a screw-cap polypropylene transport tube. Do not freeze gel-barrier tube (pour off serum first).
Patient Preparation
Patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample.
Storage Instructions
Room temperature
Causes for Rejection
Heat-inactivated specimens; cord blood; cadaveric specimens; or body fluid other than serum or EDTA plasma; gross hemolysis; excessive lipemia; improper labeling
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |
Other tests from different labs that may be relevant